Positive data indicates likely therapeutic effect of Alzheimer’s drug
Labiotech.eu,
Positive phase 2a clinical data from an Alzheimer’s disease (AD) biomarker study, has been announced today (October 10).
Positive phase 2a clinical data from an Alzheimer’s disease (AD) biomarker study, has been announced today (October 10).
Guo T, Korman D, La Joie R, Shaw LM, Trojanowski JQ, Jagust WJ, Landau SM, Alzheimer’s Disease Neuroimaging Initiative.